MARGETUXIMAB-CMKB: 25 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
25
Total FAERS Reports
8 (32.0%)
Deaths Reported
3
Hospitalizations
25
As Primary/Secondary Suspect
1
Life-Threatening
Prescription
Status
FDA Application: 761150 ·
First Report: 20210101 · Latest Report: 20230213
What Are the Most Common MARGETUXIMAB-CMKB Side Effects?
#1 Most Reported
Disease progression
5 reports (20.0%)
#2 Most Reported
Death
5 reports (20.0%)
#3 Most Reported
Chills
3 reports (12.0%)
All MARGETUXIMAB-CMKB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 5 | 20.0% | 5 | 0 |
| Disease progression | 5 | 20.0% | 2 | 0 |
Who Reports MARGETUXIMAB-CMKB Side Effects? Age & Gender Data
Gender: 100.0% female, 0.0% male. Average age: 60.1 years. Most reports from: US. View detailed demographics →
Is MARGETUXIMAB-CMKB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 8 | 4 | 0 |
| 2022 | 5 | 0 | 2 |
| 2023 | 1 | 0 | 0 |
What Is MARGETUXIMAB-CMKB Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 11 |
| Breast cancer metastatic | 9 |
| Her2 positive breast cancer | 5 |
Official FDA Label for MARGETUXIMAB-CMKB
Official prescribing information from the FDA-approved drug label.